CCEL stock forecast
Our latest prediction for Cryo-Cell International, Inc.'s stock price was made on the Nov. 23, 2022 when the stock price was at 4.84$.
In the short term (2weeks), CCEL's stock price should underperform the market by -2.04%. During that period the price should oscillate between -7.32% and +6.20%.
In the medium term (3months), CCEL's stock price should outperform the market by 10.43%. During that period the price should oscillate between -28.17% and +33.14%.
Get email alertsCreate a solid portfolio with CCEL
About Cryo-Cell International, Inc.
founded in 1989, cryo-cell is the oldest cord blood bank and was the first cord blood bank to separate and store stem cells in 1992. today, the company has over 270,000 clients worldwide. since inception, 100% of our clients’ specimens have been successfully viable upon thaw. our services include umbilical cord blood, cord tissue and menstrual stem cell banking. cryo-cell operates its own state-of-the-art processing, testing and cryopreservation operation. we are in complete control of every step, ensuring the highest quality available today.
At the moment the company generates 6M USD in revenues.
On its last earning announcement, the company reported a profit of 0.16$ per share.
The book value per share is -1.26$
Three months stock forecastNov. 23, 2022
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
6M | - | 2M | 44.88% | 1M | 0.16 | - | - | 8M | -1.26 | - | - | - |